Location History:
- Yardley, PA (US) (2003)
- Royersford, PA (US) (2007 - 2009)
Company Filing History:
Years Active: 2003-2009
Title: Edward Martin Matelan: Innovator in Anti-inflammatory Agents
Introduction
Edward Martin Matelan, hailing from Royersford, PA, is a distinguished inventor noted for his contributions in the field of pharmaceutical innovations. With four patents to his name, Matelan's work primarily revolves around compounds that serve in the treatment of various diseases, particularly those mediated by liver X receptors (LXR).
Latest Patents
Among his latest inventions, Matelan has created a series of compounds including the [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones. These compounds provide anti-inflammatory agents characterized by a specific structural formula, which encompasses variations such as N-oxides, pharmaceutically acceptable salts, and prodrugs. Another significant innovation from Matelan includes various forms of indazoles, compounds designed to be effective in the treatment or inhibition of LXR-mediated diseases.
Career Highlights
Edward Matelan is currently associated with Wyeth, a company renowned for its commitment to healthcare and pharmaceutical advancements. His role involves delving into innovative research, leading to the development of groundbreaking therapies that address critical health issues.
Collaborations
Matelan has worked alongside notable colleagues, including Robert J. Steffan and Mark Anthony Ashwell. These collaborations have fostered an environment of creativity and innovation, contributing to the successful patenting of several important compounds.
Conclusion
With a robust portfolio of patents and a significant position at Wyeth, Edward Martin Matelan continues to make strides in the realm of pharmaceutical sciences. His work not only evidences his ingenuity as an inventor but also illustrates the impact of collaboration in driving innovation within the industry.